drugset / Trial / NCT06523101
A Study of PJ009 in Healthy Adult Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
The main aim of this clinical trial is to assess the safety of PJ009 in healthy adult volunteers aged 18-45. The main questions it aims to answer are: * Is PJ009 safe in healthy adult? Participants will * Receive single dose of PJ009 or placebo according to weight, and then multiple doses daily for 7 days, * Stay in hospital for assessment.
Timeline
- Start
- 2023-02-28
- Primary completion
- 2023-05-15
- Completion
- 2023-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PJ009 | Unknown | — | Subcutaneous |